Member Info for lambo222

Agree it won’t hit £250m Mcap pre results, but £100m easily achievable imo which is a 7 bagger from current levels and that’s without any other positive news from the pipeline… just need that magic FDA approved rns

Just looking back at the last phase 3 trial… sp went from 22p at the start of the trial to 180p ahead of results… and that was with plenty of Lanstead dilution along the way, be interesting to see if history repeats itself, obviously if it does then this is the bargain of a lifetime at 17m Mcap, think previously 180p gave an Mcap of around £250m to plenty of scope for life changing gains here, and that’s without any trial success just in the ride up on the phase 3 trial. Be interesting to see what the share price here is in 3 years time, all this needs is FDA approval for the trial to begin and I feel the story here starts all over again, just need that magic FDA approve phase 3 trial rns, now that will be a day to celebrate for shareholders

He has had nearly a year to sign a rig contract yet still nothing, maybe they don’t have pens in his Italian villa….

Massive dilution in the last 5 years though, 1.5p would mean an Mcap of about £14m not that unrealistic if they don’t drill this year imo, why would the Chinese give matd their equipment when they hve their owns wells to work in first? Doesn’t make good business sense with the price of oil been so high the Chinese have their own work programs to complete before they even think about doing anything in Mongolia.. let’s see I personally also don’t see them drilling this year if nothing by July is finished for 2022 imo

You can’t even send a parcel to China atm without it been quarantined for 14 days… and that’s after it takes weeks to arrive, not a chance imo a Chinese rig and drill team will be allowed into Mongolia when there is a massive backlog of drills to be done in China, Petro China are not going to prioritise matd over their own work programs that are hugely behind schedule. I wouldn’t be surprised to see the matd programme delayed until Q2 2023… if this happens you should be able to pick the shares up sub 1.5p, too risky at present with too many unknowns, all imo

At least they are finally at the final step with the FDA now after 2 years… approval and it’s a different investment proposition all together, think the FDA have 45 days to review each submission so should hear something soon

Haha seems like we are at the lows so doesn’t look like it wants to go lower, it’s boom or bust for shareholders here now, approval by the FDA and they have a $25m fully funded phase 3 trial ready to commence. Think historically the Mcap went from £30m at the start of the last phase 3 trial to bear £300m ahead of results… so the potential is there for an epic rise it always has been, they just need to finally get it started which has taken far far too long

Who is the fool? Me or you? Ok send me your Twitter name and we can have a friendly wager

Happy to have a bet with you that matd do not drill in 2022… they don’t even have a rig contract, if you fancy a bet let me know we can arrange on Twitter

MB should resign if they don’t drill again this year, wouldn’t be surprised to see this sub 1.5p if they announce no drilling until 2023 which seems likely imo total shambles

Only £1.6m left as of 31 December 2021… loss last year was £8m

It will be interesting to see if they change the nominal share value at the AGM… they will obviously need to raise money again soon given the ridiculous cash burn

Was obvious really, huge delays are never good news as I said earlier sorry to all holders, shafted again

So how come they didn’t release the full results from the last drill campaign?

Sorry to all holders, if they had good results they would be shouting it from the rooftops, probs hit 0.3p if it’s a write off imo then not much left

But the point is Lanstead have two concurrent spiral agreements running atm so the selling pressure just from Lanstead alone massively outweighs any small volume buying pressure. So when there are more sells than buys the price falls that’s just simple market mechanics, only when more buying than selling takes place can it rise hence why I can see this hitting 4p before any news lands from the FDA which could be months away, no timeframe was given

So with Lanstead selling shares each and every month as per the death spiral finance agreement, who is buying the shares to make the price rise? Private investors need to buy all Lanstead shares each month just to stop the price falling, charts are fine but not on low volume shares like this with death spiral funding

This agreement ends in June so Lanstead will most likely be dumping the last of those shares in June imo could see 4p here over the next few months as Lanstead continue their selling, this death spiral agreement is illogical for a company with such low buy volume it just doesn’t work for the company or shareholders

Cash at 31st Dec £1.6m after the placing…. So with such huge losses it won’t be long before they are out with the begging bowl for more death spiral funding imo

Shocking rns, be surprised if 5p support holds after those results, won’t be long before another fund raise imo lifestyle company with death spiral finance via Lanstead